A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Male Circumcision and Serologically Determined Human Papillomavirus Infection in a Birth Cohort
2009
Cancer Epidemiology, Biomarkers and Prevention
Circumcision has been reported to protect against infection with human papillomavirus (HPV) in men, but results have been inconsistent. We followed males in a birth cohort born in Dunedin, New Zealand, in 1972 and 1973 from age 3 to 32 years. Seropositivity at age 32 years for the oncogenic types HPV-16 and 18, and the nononcogenic types 6 and 11, was studied in relation to maternal reports of circumcision status at age 3 for 450 men. Seropositivity to any of these types was associated with
doi:10.1158/1055-9965.epi-08-0353
pmid:19124496
fatcat:tusoqaj6jfeexmzzzyvvdyrfhq